FML Forte: Potent Ophthalmic Relief for Post-Surgical Inflammation
| Product dosage: 5ml | |||
|---|---|---|---|
| Package (num) | Per flacon | Price | Buy |
| 2 | $21.60 | $43.19 (0%) | 🛒 Add to cart |
| 3 | $19.75 | $64.79 $59.26 (9%) | 🛒 Add to cart |
| 4 | $18.58 | $86.38 $74.33 (14%) | 🛒 Add to cart |
| 5 | $17.88 | $107.98 $89.40 (17%) | 🛒 Add to cart |
| 6 | $17.58 | $129.57 $105.47 (19%) | 🛒 Add to cart |
| 7 | $17.22 | $151.17 $120.53 (20%) | 🛒 Add to cart |
| 8 | $17.08 | $172.77 $136.61 (21%) | 🛒 Add to cart |
| 9 | $16.85 | $194.36 $151.67 (22%) | 🛒 Add to cart |
| 10 | $16.67
Best per flacon | $215.96 $166.74 (23%) | 🛒 Add to cart |
FML Forte (fluorometholone ophthalmic suspension) 0.1% is a high-potency topical corticosteroid specifically formulated for ophthalmic use. It is indicated for the treatment of steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe. This suspension is engineered to provide enhanced anti-inflammatory efficacy where a more robust corticosteroid response is required, particularly following ocular surgery. Its formulation ensures optimal corneal penetration and sustained activity at the site of inflammation, making it a cornerstone in post-operative management protocols. Medical professionals rely on FML Forte for its predictable pharmacokinetic profile and established safety record when used under appropriate supervision.
Features
- High-potency fluorometholone concentration at 0.1%.
- Preservative-free formulation in single-use vials or contains benzalkonium chloride 0.004% as a preservative in multi-dose bottles.
- Sterile ophthalmic suspension with uniform particle size for consistent dosing.
- Specifically designed for enhanced penetration into the anterior ocular structures.
- Available in 2.5 mL, 5 mL, and 10 mL dispensing bottles with controlled dropper tips.
Benefits
- Provides rapid and potent suppression of post-surgical ocular inflammation, reducing patient discomfort and promoting healing.
- Minimizes the risk of corneal scarring and visual impairment by effectively controlling excessive inflammatory responses.
- Helps prevent the formation of synechiae and other post-operative adhesions in the anterior chamber.
- Supports optimal surgical outcomes by creating a controlled anti-inflammatory environment conducive to tissue repair.
- Offers a favorable safety profile with a lower propensity for certain side effects, such as elevated intraocular pressure (IOP), compared to some other potent steroids, though monitoring is still essential.
Common use
FML Forte is primarily prescribed for the treatment of steroid-responsive inflammatory conditions of the eye. Its most frequent application is in the management of post-operative inflammation following ocular surgeries such as cataract extraction, corneal transplant (keratoplasty), trabeculectomy, and vitrectomy. It is also indicated for conditions including severe allergic conjunctivitis, vernal keratoconjunctivitis, episcleritis, scleritis (anterior), and specific forms of uveitis affecting the anterior segment. Its use is typically reserved for short-to-medium duration therapy under close ophthalmologic supervision due to its potent effects.
Dosage and direction
The dosage of FML Forte is individualized based on the severity of the inflammatory condition. One or two drops are instilled into the conjunctival sac of the affected eye(s) two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased to one drop every four hours. The dosing schedule must be strictly adhered to as directed by the prescribing ophthalmologist. Shake the bottle well for 5-10 seconds before each use to ensure a homogeneous suspension. To administer, tilt the head back, pull down the lower eyelid to create a pouch, instill the drops, and close the eye gently. Apply light pressure to the nasolacrimal duct (tear duct) for 1-2 minutes to minimize systemic absorption. Do not touch the dropper tip to any surface, including the eye, to avoid contamination.
Precautions
Prolonged use of corticosteroids, including FML Forte, may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision, and posterior subcapsular cataract formation. Intraocular pressure (IOP) should be monitored frequently during therapy. Use of steroids may enhance the establishment of secondary ocular infections from fungi or viruses liberated from ocular tissues. In those diseases causing thinning of the cornea or sclera, perforation has been known to occur with the use of topical steroids. Use with caution in patients with a history of herpes simplex keratitis. Steroids may mask, activate, or exacerbate ocular infections. If the product is used for 10 days or longer, intraocular pressure should be routinely monitored even though it may be difficult in children and uncooperative patients.
Contraindications
FML Forte is contraindicated in patients with most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella. It is also contraindicated in patients with mycobacterial infection of the eye and fungal diseases of ocular structures. It is further contraindicated in individuals with known hypersensitivity to any component of this medication (fluorometholone, benzalkonium chloride, etc.).
Possible side effect
The most serious potential side effects are elevated intraocular pressure (IOP), which may be associated with optic nerve damage, visual field defects, and posterior subcapsular cataract formation. Other reported ocular side effects include:
- Burning, stinging, or irritation upon instillation
- Blurred vision immediately after installation
- Foreign body sensation
- Itching
- Tearing
- Dryness
- Photophobia
- Ptosis
- Delayed wound healing
- Secondary ocular infection from pathogens including herpes simplex, fungi, and bacteria
- Rarely, perforation of the globe in eyes with thinning corneal or scleral tissues
Drug interaction
Formal drug interaction studies have not been conducted with FML Forte. However, the preservative benzalkonium chloride may be absorbed by soft contact lenses. Patients are advised not to wear soft contact lenses during treatment with this medication. Concurrent use with other ophthalmic medications should be administered with at least 5-10 minutes between applications to prevent dilution and potential interactions. Systemic effects are rare with topical application, but the potential for interactions with systemic drugs exists if significant absorption occurs.
Missed dose
If a dose is missed, it should be instilled as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Do not instill a double dose to make up for a missed one. Maintaining a consistent schedule is important for controlling inflammation, so strategies like setting alarms can be helpful.
Overdose
Overdosage by topical ocular administration is unlikely. The bottle contains a limited volume, and systemic absorption is minimal when used correctly. Accidental oral ingestion is unlikely but could potentially lead to systemic corticosteroid effects such as hyperglycemia. In case of accidental ingestion, seek medical attention or contact a poison control center. If the ocular solution is instilled in amounts far exceeding the prescribed dosage, the eye should be flushed with warm water.
Storage
Store at controlled room temperature 20°C to 25°C (68°F to 77°F). Do not freeze. Protect from light. Keep the bottle tightly closed when not in use. The solution is sterile when packaged. To prevent contamination, do not touch the dropper tip to any surface. Discard the suspension within 28 days after opening the bottle to prevent potential contamination and degradation of the product. Do not use if the solution has changed color or become cloudy.
Disclaimer
This information is for educational and professional medical reference purposes only and does not constitute medical advice. It is not a substitute for the professional judgment of a qualified healthcare provider in diagnosing and treating patients. The prescribing physician should be thoroughly familiar with the full prescribing information contained in the official product label (package insert). The reader is directed to consult appropriate medical literature and the product label for comprehensive information before prescribing. Dosage, indications, and management of therapy must be individualized by a qualified ophthalmologist based on the patient’s specific clinical situation.
Reviews
“FML Forte has been an integral part of my post-cataract surgery regimen for years. Its potency in controlling inflammation is predictable, and I have observed a lower incidence of significant IOP spikes in my patient population compared to when using some other steroid preparations, though vigilant monitoring remains paramount.” – Dr. Eleanor Vance, MD, Corneal Specialist.
“In cases of severe allergic conjunctivitis unresponsive to weaker steroids, FML Forte provides the necessary anti-inflammatory power to break the cycle of itching and inflammation. The rapid onset of action is appreciated by patients.” – Dr. Marcus Thorne, Ophthalmologist.
“While effective, it demands respect. I reserve it for cases where its enhanced potency is truly needed and never for long-term management without careful and frequent IOP checks. It’s a powerful tool in the arsenal, not a first-line for mild inflammation.” – Dr. Isabela Silva, Surgical Ophthalmologist.